Active Ingredient History

  • Now
The drug combination bismuth subcitrate/metronidazole/tetracycline is used for the treatment of peptic ulcer with an infection by the bacterium Helicobacter pylori. It is taken by mouth.   Wikipedia

  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No
1001277 | bi-citrate | biselic | bismofarma | bismuth citrate | bismuth potassium citrate | bismuth potassium citrate. | bismuth subcitrate | bismuth subcitrate potassium | bismuth tripotassium dicitrate | colloidal bismuth subcitrate | denol | de-nol | de-noltab | gastrodenol | pylera | sucrato | tripotassium bismuth dicitrate | tripotassium dicitrate bismuthate | tripotassium dicitratobismuthate | tripotassium-dicitrato bismuthate | ventrisol-polfa


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue